{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:46:58Z","timestamp":1793317618909,"version":"4.5.0"},"reference-count":22,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.2967\/jnumed.118.215913","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T17:05:55Z","timestamp":1533229555000},"page":"386-392","source":"Crossref","is-referenced-by-count":720,"title":["<sup>68<\/sup>\n                    Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers"],"prefix":"10.2967","volume":"60","author":[{"given":"Frederik L.","family":"Giesel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred M.","family":"Marschalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Loktev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencke","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Flechsig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"2021051712130244000_60.3.386.1","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201300095"},{"key":"2021051712130244000_60.3.386.2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med Chem Lett."},{"key":"2021051712130244000_60.3.386.3","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1021\/jm400351a","article-title":"Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase","volume":"56","author":"Poplawski","year":"2013","journal-title":"J Med Chem."},{"key":"2021051712130244000_60.3.386.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210435"},{"key":"2021051712130244000_60.3.386.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210443"},{"key":"2021051712130244000_60.3.386.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1422-4"},{"key":"2021051712130244000_60.3.386.7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13550-017-0339-3","article-title":"IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms","volume":"7","author":"Andersson","year":"2017","journal-title":"EJNMMI Res."},{"key":"2021051712130244000_60.3.386.8","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712130244000_60.3.386.9","doi-asserted-by":"crossref","unstructured":"Cristy M Eckerman KF . Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. Oak Ridge, TN: Oak Ridge National Laboratory; 1987. ORNL\/TM-8381\/V1\u2013V7.","DOI":"10.2172\/6233735"},{"key":"2021051712130244000_60.3.386.10","first-page":"1","article-title":"ICRP publication 110: realistic reference phantoms\u2014an ICRP\/ICRU joint effort. A report of adult reference computational phantoms","volume":"39","author":"Menzel","year":"2009","journal-title":"Ann ICRP."},{"key":"2021051712130244000_60.3.386.11","doi-asserted-by":"publisher","DOI":"10.1177\/0146645315613480"},{"key":"2021051712130244000_60.3.386.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.120600"},{"key":"2021051712130244000_60.3.386.13","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00259-016-3424-3","article-title":"Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC: a PSMA specific probe for PET imaging of prostate cancer","volume":"43","author":"Pfob","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130244000_60.3.386.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3419-0"},{"key":"2021051712130244000_60.3.386.15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/BF00175858","article-title":"Effective dose from radiopharmaceuticals","volume":"19","author":"Johansson","year":"1992","journal-title":"Eur J Nucl Med."},{"key":"2021051712130244000_60.3.386.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.062703"},{"key":"2021051712130244000_60.3.386.17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrgastro.2013.42","article-title":"Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis","volume":"10","author":"Strobel","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"2021051712130244000_60.3.386.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2021051712130244000_60.3.386.19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"177Lu-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol."},{"key":"2021051712130244000_60.3.386.20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","article-title":"Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis","volume":"809","author":"Egger","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"2021051712130244000_60.3.386.21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12396"},{"key":"2021051712130244000_60.3.386.22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","article-title":"Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction","volume":"87","author":"Tillmanns","year":"2015","journal-title":"J Mol Cell Cardiol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.215913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:36:59Z","timestamp":1621269419000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.215913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,1]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.2967\/jnumed.118.215913"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.215913","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]}}}